Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

January 2023; Volume 43,Issue 1

Experimental Studies

  • Open Access
    Effect of Antibiotic Treatment on Attenuated Salmonella typhimurium VNP20009 Mediated Schwannoma Growth Control
    SHERIF G. AHMED and GARY J. BRENNER
    Anticancer Research January 2023, 43 (1) 1-6; DOI: https://doi.org/10.21873/anticanres.16127
  • Open Access
    Devitalization of Glioblastoma Cancer Cells by Non-invasive Physical Plasma: Modulation of Proliferative Signalling Cascades
    SEBASTIAN LEHMANN, SANDRA BIEN-MÖLLER, SASCHA MARX, SANDER BEKESCHUS, HENRY W.S. SCHROEDER, ALEXANDER MUSTEA and MATTHIAS B. STOPE
    Anticancer Research January 2023, 43 (1) 7-18; DOI: https://doi.org/10.21873/anticanres.16128
  • Open Access
    Recombinant Oral Methioninase (o-rMETase) Combined With Oxaliplatinum Plus 5-Fluorouracil Improves Survival of Mice With Massive Colon-Cancer Peritoneal Carcinomatosis
    MIN JEONG KIM, QINGHONG HAN, MICHAEL BOUVET, ROBERT M. HOFFMAN and JUN HO PARK
    Anticancer Research January 2023, 43 (1) 19-24; DOI: https://doi.org/10.21873/anticanres.16129
  • Open Access
    CD9-positive Exosomes Derived from Cancer-associated Fibroblasts Might Inhibit the Proliferation of Malignant Melanoma Cells
    NAHO FUJII, MASAKAZU YASHIRO, TAKAHARU HATANO, HEISHIRO FUJIKAWA and HISASHI MOTOMURA
    Anticancer Research January 2023, 43 (1) 25-33; DOI: https://doi.org/10.21873/anticanres.16130
  • Open Access
    miR-877-3p as a Potential Tumour Suppressor of Oesophageal Squamous Cell Carcinoma
    TAKUMA FUKUDA, HAYATO BABA, TOMOYUKI OKUMURA, MITSURO KANDA, TAKAHISA AKASHI, HARUYOSHI TANAKA, TAKESHI MIWA, TORU WATANABE, KATSUHISA HIRANO, SHINICHI SEKINE, ISAYA HASHIMOTO, KAZUTO SHIBUYA, SHOZO HOJO, ISAKU YOSHIOKA, KOSHI MATSUI, YASUHIRO KODERA and TSUTOMU FUJII
    Anticancer Research January 2023, 43 (1) 35-43; DOI: https://doi.org/10.21873/anticanres.16131
  • You have access
    Pathological Significance of Kidney and Brain Expressed Protein (KIBRA) in Clear Cell Renal Cell Carcinoma
    YOSHIAKI NAGASHIMA, KENSUKE MITSUNARI, TOMOHIRO MATSUO, YUICHIRO NAKAMURA, YASUYOSHI MIYATA and KOJIRO OHBA
    Anticancer Research January 2023, 43 (1) 45-51; DOI: https://doi.org/10.21873/anticanres.16132
  • You have access
    Cervical Adenocarcinoma: A Still Under-investigated Malignancy
    SABINA PISTOLESI, GIUSEPPE NICOLÒ FANELLI, FRANCESCO GIUDICE, FRANCESCA GARBINI, ANTONIO GIUSEPPE NACCARATO, STEFANIA COSIO, MARTA CARETTO and ANGIOLO GADDUCCI
    Anticancer Research January 2023, 43 (1) 53-58; DOI: https://doi.org/10.21873/anticanres.16133
  • You have access
    Endoluminal Suture-technique for the Stomach Closure of an Experimental Model
    PETER HALVAX, BALAZS NEMETH, ISTVAN KISS, ANDRAS PAPP and ANDRAS VERECZKEI
    Anticancer Research January 2023, 43 (1) 59-61; DOI: https://doi.org/10.21873/anticanres.16134
  • You have access
    Cytotoxicity of Human Hepatic Intrasinusoidal Gamma/Delta T Cells Depends on Phospho-antigen and NK Receptor Signaling
    YOORHA KANG, MINA HAN, MINSONG KIM, HYUN JU HWANG, BYUNG CHAN AHN, EUNYOUNG TAK, GI-WON SONG, SHIN HWANG, KYUNG-NAM KOH, DONG-HWAN JUNG and NAYOUNG KIM
    Anticancer Research January 2023, 43 (1) 63-73; DOI: https://doi.org/10.21873/anticanres.16135
  • You have access
    Phosphofructokinase 1 Platelet Isoform Enhances VEGF Expression in Part Through HIF-1α Up-regulation in Breast Cancer
    JONG-HO LEE
    Anticancer Research January 2023, 43 (1) 75-84; DOI: https://doi.org/10.21873/anticanres.16136
  • You have access
    Preclinical Platform Using a Triple-negative Breast Cancer Syngeneic Murine Model to Evaluate Immune Checkpoint Inhibitors
    NAR BAHADUR KATUWAL, NAHEE PARK, KAMAL PANDEY, MIN SIL KANG, SA DEOK HONG, MITHUN GHOSH, SEUL-GI KIM, YOUNG BIN CHO, JIN HUR, SEUNG KI KIM and YONG WHA MOON
    Anticancer Research January 2023, 43 (1) 85-95; DOI: https://doi.org/10.21873/anticanres.16137
  • You have access
    Asymmetric Dimethylarginine in an NMU-induced Rat Mammary Tumor Model
    IWONA MALICKA, HELENA MARTYNOWICZ, PIOTR DZIĘGIEL, MARZENNA PODHORSKA-OKOŁÓW, MAREK WOŹNIEWSKI and ANDRZEJ SZUBA
    Anticancer Research January 2023, 43 (1) 97-103; DOI: https://doi.org/10.21873/anticanres.16138

Clinical Studies

  • Open Access
    Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal Cancer
    HIKARI CHIDIMATSU, RYOUICHI TSUNEDOMI, YUKI NAKAGAMI, MING XU, MASAO NAKAJIMA, CHIYO NAKASHIMA-NAKASUGA, SHINOBU TOMOCHIKA, SHIN YOSHIDA, NOBUAKI SUZUKI, YUSAKU WATANABE, HIROTO MATSUI, YOSHITARO SHINDO, YUKIO TOKUMITSU, MICHIHISA IIDA, SHIGERU TAKEDA, TATSUYA IOKA, TOMIO UENO, TSUYOSHI TANABE, YOSHINOBU HOSHII, SHOICHI HAZAMA and HIROAKI NAGANO
    Anticancer Research January 2023, 43 (1) 105-114; DOI: https://doi.org/10.21873/anticanres.16139
  • Open Access
    CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer
    YANGZHI HU, LIJUAN HUANG, KAILAI ZHAO, YUAN LI, NATHAN T. GIVENS, AIDAN J. HESLIN, ZULIANG DENG, LIEQUAN CAO and YUJIANG FANG
    Anticancer Research January 2023, 43 (1) 115-126; DOI: https://doi.org/10.21873/anticanres.16140
  • Open Access
    18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Tumor Immune Microenvironment Function in Early Triple-negative Breast Cancer
    YURI KIMURA, SHINSUKE SASADA, AKIKO EMI, NORIO MASUMOTO, TAKAYUKI KADOYA, KOJI ARIHIRO and MORIHITO OKADA
    Anticancer Research January 2023, 43 (1) 127-136; DOI: https://doi.org/10.21873/anticanres.16141
  • Open Access
    Prophylactic Anticoagulation in Patients With Pancreatic Adenocarcinoma: A Single Tertiary Care Center Retrospective QI Project
    SHIVANI SHAH, CHELSEA PETERSON, JIAXIANG LIU and DULABH K. MONGA
    Anticancer Research January 2023, 43 (1) 137-141; DOI: https://doi.org/10.21873/anticanres.16142
  • You have access
    Histological Risk Factors for Local Recurrence of Phyllodes Tumors of the Breast
    CAMILLE MIMOUN, LUDIVINE LEGAY, HENRI LORPHELIN, ANNE SOPHIE LEVEAU-VALLIER, FRANCOISE CORNELIS, CATHERINE MIQUEL, EVA MARCHAND, MATTHIEU MEZZADRI, LUIS TEIXEIRA, LAURENCE CAHEN-DOIDY and CYRILLE HUCHON
    Anticancer Research January 2023, 43 (1) 143-147; DOI: https://doi.org/10.21873/anticanres.16143
  • You have access
    Lymph-vascular Space Involvement and/or p53 Overexpression Correlated With the Clinical Outcome of Early-stage Endometrial Cancer Patients Treated With Adjuvant Vaginal Brachytherapy
    CONCETTA LALISCIA, ANGIOLO GADDUCCI, NATALINA COCCIA, ROBERTO MATTIONI, TAIUSHA FUENTES, MARTA CARETTO, SABINA PISTOLESI, PAOLA PUCCINI, FRANCO PERRONE, RICCARDO MORGANTI and FABIOLA PAIAR
    Anticancer Research January 2023, 43 (1) 149-156; DOI: https://doi.org/10.21873/anticanres.16144
  • Open Access
    Measurable Residual Disease Assessment Using Next-Generation Flow in Patients With Relapsed and Refractory Multiple Myeloma Treated With a Combination of Carfilzomib, Lenalidomide, and Dexamethasone
    TAKESHI YOROIDAKA, TAKESHI YAMASHITA, RYOICHI MURATA, KYOKO YOSHIHARA, SATOSHI YOSHIHARA, MIKIO UEDA, SHINJI NAKAO, KOSEI MATSUE and HIROYUKI TAKAMATSU
    Anticancer Research January 2023, 43 (1) 157-165; DOI: https://doi.org/10.21873/anticanres.16145
  • You have access
    Immunohistochemical Analysis of HER2, EGFR, and Nectin-4 Expression in Upper Urinary Tract Urothelial Carcinoma
    MAMORU HASHIMOTO, KAZUTOSHI FUJITA, EISUKE TOMIYAMA, SAIZO FUJIMOTO, SHOGO ADOMI, ERI BANNO, TAKAFUMI MINAMI, TETSUYA TAKAO, MASAHIRO NOZAWA, HIROAKI FUSHIMI, KAZUHIRO YOSHIMURA, NORIO NONOMURA and HIROTSUGU UEMURA
    Anticancer Research January 2023, 43 (1) 167-174; DOI: https://doi.org/10.21873/anticanres.16146
  • You have access
    Staple Line Reinforcement for Intracorporeal Anastomosis Reduces Time for Reconstruction During Laparoscopic Gastrectomy for Gastric Cancer
    TSUTOMU NAMIKAWA, MASATO UTSUNOMIYA, KEIICHIRO YOKOTA, MASAYA MUNEKAGE, SUNAO UEMURA, HIROMICHI MAEDA, HIROYUKI KITAGAWA, MICHIYA KOBAYASHI, KAZUHIRO HANAZAKI and SATORU SEO
    Anticancer Research January 2023, 43 (1) 175-181; DOI: https://doi.org/10.21873/anticanres.16147
  • You have access
    Utility of FDG PET at the Initial Radioiodine Therapy in Differentiated Thyroid Cancer
    MIOKO MATSUO, SHINGO BABA, KAZUKI HASHIMOTO, TAKURO ISODA, YOSHIYUKI KITAMURA, RYUNOSUKE KOGO, RINA JIROMARU, TAKAHIRO HONGO, TOMOMI MANAKO and TAKASHI NAKAGAWA
    Anticancer Research January 2023, 43 (1) 183-190; DOI: https://doi.org/10.21873/anticanres.16148
  • You have access
    Factor Analysis of Intraoperative Bleeding Loss and its Impact on Prognosis in Breast Cancer
    KOJI TAKADA, SHINICHIRO KASHIWAGI, NOZOMI IIMORI, RIKA KOUHASHI, AKIMICHI YABUMOTO, WATARU GOTO, YUKA ASANO, YUKIE TAUCHI, KANA OGISAWA, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA and KIYOSHI MAEDA
    Anticancer Research January 2023, 43 (1) 191-200; DOI: https://doi.org/10.21873/anticanres.16149
  • Open Access
    D1 Distal Pancreatectomy for Left-sided Pancreatic Ductal Adenocarcinoma Is Justifiable: A Propensity-score Matched Multicenter Study
    TARO SAKAMOTO, TAKESHI GOCHO, MASASHI TSUNEMATSU, YOSHIHIRO SHIRAI, RYOGA HAMURA, KOICHIRO HARUKI, KYOHEI ABE, TOMOYOSHI OKAMOTO, HIRONORI SHIOZAKI, SHUICHI FUJIOKA, RYOTA IWASE, YU KUMAGAI, TERUYUKI USUBA and TORU IKEGAMI
    Anticancer Research January 2023, 43 (1) 201-208; DOI: https://doi.org/10.21873/anticanres.16150
  • Open Access
    Significance of Skeletal Muscle Loss in Liver Hypertrophy in Patients Undergoing Portal Vein Embolization Before Major Hepatectomy: Assessment With Body Composition and Nutritional Indicators
    KENICHIRO ARAKI, NORIFUMI HARIMOTO, KEI SHIBUYA, AKIRA WATANABE, MARIKO TSUKAGOSHI, NORIHIRO ISHII, KEI HAGIWARA, RYO MURANUSHI, KOUKI HOSHINO, TAKAOMI SEKI and KEN SHIRABE
    Anticancer Research January 2023, 43 (1) 209-216; DOI: https://doi.org/10.21873/anticanres.16151
  • You have access
    Characteristics of Patients With Metastatic Breast Cancer Who Survived more than 10 Years
    MAMI KIKUCHI, TAKAAKI FUJII, CHIKAKO HONDA, KEIKO TANABE, YUKO NAKAZAWA, MISATO OGINO, SAYAKA OBAYASHI and KEN SHIRABE
    Anticancer Research January 2023, 43 (1) 217-221; DOI: https://doi.org/10.21873/anticanres.16152
  • You have access
    Survival Impact of Postoperative Skeletal Muscle Loss in Gastric Cancer Patients Who Underwent Gastrectomy
    KAZUYA KUWADA, SATORU KIKUCHI, SHINJI KURODA, RYUICHI YOSHIDA, KOSEI TAKAGI, KAZUHIRO NOMA, MASAHIKO NISHIZAKI, SHUNSUKE KAGAWA, YUZO UMEDA and TOSHIYOSHI FUJIWARA
    Anticancer Research January 2023, 43 (1) 223-230; DOI: https://doi.org/10.21873/anticanres.16153
  • You have access
    Evaluation of Lung and Liver Tumor Dose Coverage Treated With the CyberKnife Synchrony System With Consideration of Measured Tracking Errors
    YUICHI AKINO, HIROYA SHIOMI, NAOICHI HIGASHINAKA, TOMOHIRO KOUNO, NOBUHISA MABUCHI, FUMIAKI ISOHASHI, YUJI SEO, KEI FUJIWARA, SETSUO TAMENAGA and KAZUHIKO OGAWA
    Anticancer Research January 2023, 43 (1) 231-238; DOI: https://doi.org/10.21873/anticanres.16154
  • You have access
    Differences in Toxicity Between Ashkenazi and Sephardic Jews With Colon Cancer Treated With Adjuvant Chemotherapy: A Prospective Study
    BARUCH BRENNER, YAEL STERN, NOA GORDON, TZIPORA FUKS, TAL GRANOT, JULIET DREYER and AARON SULKES
    Anticancer Research January 2023, 43 (1) 239-245; DOI: https://doi.org/10.21873/anticanres.16155
  • You have access
    Clinical Verification on the Predictors for Febrile Neutropenia in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
    WATARU GOTO, SHINICHIRO KASHIWAGI, KOHEI MATSUOKA, NOZOMI IIMORI, RIKA KOUHASHI, AKIMICHI YABUMOTO, KOJI TAKADA, YUKA ASANO, YUKIE TAUCHI, KANA OGISAWA, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA and KIYOSHI MAEDA
    Anticancer Research January 2023, 43 (1) 247-254; DOI: https://doi.org/10.21873/anticanres.16156
  • You have access
    Papillary Thyroid Carcinoma With Squamous Dedifferentiation: A Potential Diagnostic Pitfall
    KOMAL IJAZ and FENG YIN
    Anticancer Research January 2023, 43 (1) 255-258; DOI: https://doi.org/10.21873/anticanres.16157
  • You have access
    Relationship Between C-reactive Protein-to-albumin Ratio Before and After Bowel Decompression and Prognosis in Acute Malignant Large Bowel Obstruction
    TAKUYA SHIRAISHI, HIROOMI OGAWA, ARISA YAMAGUCHI, HIDEYUKI SAITO, CHIKA KOMINE, IKUMA SHIOI, NAOYA OZAWA, KATSUYA OSONE, TAKUHISA OKADA, MAKOTO SOHDA, KEN SHIRABE and HIROSHI SAEKI
    Anticancer Research January 2023, 43 (1) 259-267; DOI: https://doi.org/10.21873/anticanres.16158
  • You have access
    Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab
    IKKO TOMISAKI, MIRII HARADA, SHIGERU SAKANO, MICHIKAZU TERADO, RYOICHI HAMASUNA, SHUJI HARADA, HIROOMI MATSUMOTO, SOICHIRO AKASAKA, YUJIRO NAGATA, AKINORI MINATO, KEN-ICHI HARADA and NAOHIRO FUJIMOTO
    Anticancer Research January 2023, 43 (1) 269-274; DOI: https://doi.org/10.21873/anticanres.16159

Special Issue on Prostate Cancer

  • Reviews

    • Open Access
      Appraising Animal Models of Prostate Cancer for Translational Research: Future Directions
      ELISABETE NASCIMENTO-GONCALVES, FERNANDA SEIXAS, RUI M. GIL DA COSTA, MARIA JOAO PIRES, MARIA JOAO NEUPARTH, DANIEL MOREIRA-GONCALVES, MARGARIDA FARDILHA, ANA I. FAUSTINO-ROCHA, BRUNO COLACO, RITA FERREIRA and PAULA A. OLIVEIRA
      Anticancer Research January 2023, 43 (1) 275-281; DOI: https://doi.org/10.21873/anticanres.16160
    • Open Access
      Diagnosing and Prognosing Bone Metastasis in Prostate Cancer: Clinical Utility of Blood Biomarkers
      GAKU YAMAMICHI, TAIGO KATO, MOTOHIDE UEMURA and NORIO NONOMURA
      Anticancer Research January 2023, 43 (1) 283-290; DOI: https://doi.org/10.21873/anticanres.16161
    • Open Access
      Transglutaminase-4 (Prostate Transglutaminase), a Potential Biological Factor and Clinical Indicator for the Diagnosis and Prognosis of Prostate Cancer
      LIN YE, ANDREW J. SANDERS and WEN G. JIANG
      Anticancer Research January 2023, 43 (1) 291-296; DOI: https://doi.org/10.21873/anticanres.16162
    • Open Access
      S-PI-RADS and PI-RRADS for Biparametric MRI in the Detection of Prostate Cancer and Post-treatment Local Recurrence
      MICHELE SCIALPI, EUGENIO MARTORANA, PIETRO SCIALPI, GIOVANNI BATTISTA SCALERA, EUGENIO BELATTI, MARIA CRISTINA AISA, ALFREDO D’ANDREA, FRANCESCO MARIA MANCIOLI, ALESSANDRO DI MARZO, FABIO TRIPPA and ALDO DI BLASI
      Anticancer Research January 2023, 43 (1) 297-303; DOI: https://doi.org/10.21873/anticanres.16163
    • Open Access
      Renal Impairment: A Major Adverse Event in Prostate Cancer Patients Treated With Androgen Deprivation Therapy
      HIROSHI MASUDA
      Anticancer Research January 2023, 43 (1) 305-309; DOI: https://doi.org/10.21873/anticanres.16164
    • Open Access
      Radiotherapy in Prostate Brain Metastases: A Review of the Literature
      CAROLINA DE LA PINTA
      Anticancer Research January 2023, 43 (1) 311-315; DOI: https://doi.org/10.21873/anticanres.16165
    • Open Access
      The Role of Genetic Polymorphisms in the Diagnosis and Management of Prostate Cancer: An Update
      LUCIO DELL’ATTI and GIANLUCA AGUIARI
      Anticancer Research January 2023, 43 (1) 317-322; DOI: https://doi.org/10.21873/anticanres.16166
    • Open Access
      Evolution of Models of Prostate Cancer: Their Contribution to Current Therapies
      ANA I. FAUSTINO-ROCHA, CATARINA JOTA-BAPTISTA, ELISABETE NASCIMENTO-GONÇALVES and PAULA A. OLIVEIRA
      Anticancer Research January 2023, 43 (1) 323-333; DOI: https://doi.org/10.21873/anticanres.16167
  • Experimental Studies

    • Open Access
      Use of Conditioned Extracellular Matrix as a Tissue-engineered Tumor Matrisome for Prostate Cancer and Melanoma Immunotherapy
      MARK A. SUCKOW and MICHAEL C. HILES
      Anticancer Research January 2023, 43 (1) 335-341; DOI: https://doi.org/10.21873/anticanres.16168
    • Open Access
      Association of Matrix Metalloproteinase-2 Genotypes With Prostate Cancer Risk
      PO-HAN LI, CHENG-HSI LIAO, WEN-CHIN HUANG, WEN-SHIN CHANG, HSI-CHIN WU, SHIH-WEI HSU, KAI-YUAN CHEN, ZHI-HONG WANG, TE-CHUN HSIA, DA-TIAN BAU and CHIA-WEN TSAI
      Anticancer Research January 2023, 43 (1) 343-349; DOI: https://doi.org/10.21873/anticanres.16169
    • Open Access
      Exploring Hypoxia in Prostate Cancer With T2-weighted Magnetic Resonance Imaging Radiomics and Pimonidazole Scoring
      MICHELLE LEECH, RALPH T.H. LEIJENAAR, TORD HOMPLAND, JOHN GAFFNEY, HEIDI LYNG and LAURE MARIGNOL
      Anticancer Research January 2023, 43 (1) 351-357; DOI: https://doi.org/10.21873/anticanres.16170
    • You have access
      LQB-118 Suppresses Migration and Invasion of Prostate Cancer Cells by Modulating the Akt/GSK3β Pathway and MMP-9/Reck Gene Expression
      THIAGO MARTINO, GRAZIELE FREITAS DE BEM, SHIRLEY VANIA MOURA SANTOS, MARSEN GARCIA PINTO COELHO, ANGELA DE CASTRO RESENDE, CHAQUIP NETTO, PAULO ROBERTO RIBEIRO COSTA, GRAÇA JUSTO and KATIA COSTA DE CARVALHO SABINO
      Anticancer Research January 2023, 43 (1) 359-367; DOI: https://doi.org/10.21873/anticanres.16171
    • You have access
      An MGMT Allelic Variant Can Affect Biochemical Relapse in Prostate Cancer Patients
      HECTOR HUGO FURINI, KEVIN SANTIAGO DE SOUZA QUENZO FUKUSHIMA, MONYSE DE NÓBREGA, MARILESIA FERREIRA DE SOUZA, MILENE ROLDÃO SOUZA RODRIGUES, BEATRIZ BOCATTE DE MATTOS, ROBERTA LOSI GUEMBAROVSKI, PAULO EMÍLIO FUGANTI, ANDREA NAME COLADO SIMÃO, TAMIRES FLAUZINO and ILCE MARA DE SYLLOS CÓLUS
      Anticancer Research January 2023, 43 (1) 369-379; DOI: https://doi.org/10.21873/anticanres.16172
    • You have access
      Association of Matrix Metalloproteinase-7 Genotypes With Prostate Cancer Risk
      CHENG-HSI LIAO, WEN-SHIN CHANG, WEI-LIN HSU, PEI-SHIN HU, HSI-CHIN WU, SHIH-WEI HSU, BO-REN WANG, TE-CHENG YUEH, CHAO-HSUAN CHEN, TE-CHUN HSIA, WEN-CHIN HUANG, DA-TIAN BAU and CHIA-WEN TSAI
      Anticancer Research January 2023, 43 (1) 381-387; DOI: https://doi.org/10.21873/anticanres.16173
    • You have access
      Chalcone Derivatives Suppress Proliferation and Migration of Castration-resistant Prostate Cancer Cells Through FAK-mediated DNA Damage
      HAINIAO XIAO, ZHIGANG WU, QINQUAN WANG, CHAOFENG ZHOU, FENG LU and YUNBEI XIAO
      Anticancer Research January 2023, 43 (1) 389-403; DOI: https://doi.org/10.21873/anticanres.16174
    • You have access
      CBCT-based Prostate IGRT With and Without Implanted Markers: Assessment of Geometric Corrections and Time for Completion
      LUIGI DE CICCO, LUCA MARZOLI, RITA LORUSSO, ROSSELLA MARGHERITA MANCUSO, ELENA PETAZZI, ANGELO GIOVANNI LANCENI, ELISA DELLA BOSCA, SANDRA BUTTIGNOL, ANTONIO STARACE, CLAUDIO VERUSIO and BARBARA BORTOLATO
      Anticancer Research January 2023, 43 (1) 405-408; DOI: https://doi.org/10.21873/anticanres.16175
    • You have access
      Following the Trend: A Comparative Analysis of Public Engagement and Funding for Annual Prostate and Breast Cancer Campaigns Using Google Trends
      JAMES R. M. COLBOURNE, JASON T. TONIOLO, ANDREI DIACON and NATHAN LAWRENTSCHUK
      Anticancer Research January 2023, 43 (1) 409-415; DOI: https://doi.org/10.21873/anticanres.16176
  • Clinical Studies

    • Open Access
      Integrin Expression in Localized Prostate Cancer: A TCGA and MSKCC Cohort-based Exploratory In Silico Analysis
      MANUEL NEUBERGER, LISA FREY, KATJA NITSCHKE, FREDERIK WESSELS, NIKLAS WESTHOFF, FRANK WALDBILLIG, MALIN NIENTIEDT, FRIEDRICH HARTUNG, JOST VON HARDENBERG, MAURICE STEPHAN MICHEL, PHILIPP ERBEN, PHILIPP NUHN and THOMAS STEFAN WORST
      Anticancer Research January 2023, 43 (1) 417-428; DOI: https://doi.org/10.21873/anticanres.16177
    • Open Access
      Prostate-specific Antigen Kinetics During Androgen-deprivation Therapy Predict Response to Enzalutamide in Metastatic Castration-resistant Prostate Cancer
      YUJIRO NAGATA, TAKUO MATSUKAWA, IKKO TOMISAKI and NAOHIRO FUJIMOTO
      Anticancer Research January 2023, 43 (1) 429-436; DOI: https://doi.org/10.21873/anticanres.16178
    • You have access
      Androgen Deprivation Therapy Unrelated to Alzheimer’s Disease in the UK Biobank Cohort
      STEVEN LEHRER and PETER H. RHEINSTEIN
      Anticancer Research January 2023, 43 (1) 437-440; DOI: https://doi.org/10.21873/anticanres.16179
    • You have access
      Clinical Value of Magnetic Resonance Imaging Combined With Serum Prostate-specific Antigen, Epithelial Cadherin and Early Prostate Cancer Antigen 2 In Diagnosis of Prostate Cancer
      KUN LI, QINGXIA LUAN, JUNZE ZHENG, RUIDONG LI, LINKUN LI, YEQUAN SUN and DONGHUI LIU
      Anticancer Research January 2023, 43 (1) 441-447; DOI: https://doi.org/10.21873/anticanres.16180
    • Open Access
      Assessment of Prostate Carcinoma Aggressiveness: Relation to 68Ga-PSMA-11-PET/MRI and Gleason Score
      JIŘÍ FERDA, ONDŘEJ HES, MILAN HORA, EVA FERDOVÁ, JAN PERNICKÝ, VLADIMIR RUDNEV, LADISLAV PECEN, ONDŘEJ TOPOLČAN and HYNEK MÍRKA
      Anticancer Research January 2023, 43 (1) 449-453; DOI: https://doi.org/10.21873/anticanres.16181
    • Open Access
      Drugs Showing Real-world Efficacy for Nocturia in Patients With Bladder Storage Symptoms
      KAZUNA TSUBOUCHI, NAOTAKA GUNGE, WATARU MATSUOKA, TAIKI EMOTO, TAKESHI MIYAZAKI, KOSUKE TOMINAGA, YU OKABE, HIROSHI MATSUZAKI, SHINTARO ASO, MASAHIRO TACHIBANA, CHIZURU NAKAGAWA, AIKO FUJIKAWA, NOBUYUKI NAKAMURA, HIROFUMI MATSUOKA and NOBUHIRO HAGA
      Anticancer Research January 2023, 43 (1) 455-461; DOI: https://doi.org/10.21873/anticanres.16182
    • You have access
      Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience
      ONDREJ FIALA, PETR HOSEK, HANA KORUNKOVA, MILAN HORA, JIRI KOLAR, JINDRA WINDRICHOVA, ONDREJ SOREJS, ONDREJ TOPOLCAN, IVAN TRAVNICEK, HANA SEDLACKOVA and JINDRICH FINEK
      Anticancer Research January 2023, 43 (1) 463-471; DOI: https://doi.org/10.21873/anticanres.16183
    • You have access
      Effects on Life Expectancy of Treatment Decisions in Patients With Non-metastatic Prostate Cancer
      AKIRA TACHIBANA, SHUNTA HORI, YASUSHI NAKAI, MAKITO MIYAKE, KAZUMASA TORIMOTO, KIYOHIDE FUJIMOTO and NOBUMICHI TANAKA
      Anticancer Research January 2023, 43 (1) 473-483; DOI: https://doi.org/10.21873/anticanres.16184
    • You have access
      Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate Hyperplasia
      LI-WEN CHANG, SHIAN-SHIANG WANG, CHENG-KUANG YANG, KEVIN LU, CHUAN-SHU CHEN, CHEN-LI CHENG, SHENG-CHUN HUNG, KUN-YUAN CHIU, CHIANN YI HSU and JIAN-RI LI
      Anticancer Research January 2023, 43 (1) 485-491; DOI: https://doi.org/10.21873/anticanres.16185
    • You have access
      Bone Health Care Pathway for Non-metastatic Prostate Cancer Patients on Radiation and Androgen Deprivation Therapy
      ISABELLA PALUMBO, CARMELINDA RUGGIERO, ELEONORA FESTA, MICHELANTONIO DE FANO, MARTA BARONI, RITA BELLAVITA, GIANLUCA INGROSSO, SIMONETTA SALDI, MICHELE DURANTI, PATRIZIA MECOCCI, ALBERTO FALORNI and CYNTHIA ARISTEI
      Anticancer Research January 2023, 43 (1) 493-499; DOI: https://doi.org/10.21873/anticanres.16186
    • You have access
      A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer
      MARIA ROSARIA VALERIO, VINCENZO SERRETTA, DEMETRIO ARICO, IVAN FAZIO, VINCENZO ALTIERI, SERGIO BALDARI, MICHELE PENNISI, ANDREA GIRLANDO, MASSIMILIANO SPADA, CRISTINA SCALISI GESOLFO, MARCO MESSINA, CARLO MESSINA, LEONE GIORGIA, GIOVANNI SORTINO, ALFIO DI GRAZIA, ROSSELLA GUGGINO, NICOLO BORSELLINO, DARIO PIAZZA and VITTORIO GEBBIA
      Anticancer Research January 2023, 43 (1) 501-508; DOI: https://doi.org/10.21873/anticanres.16187

Corrigenda

  • You have access
    Corrigenda
    Anticancer Research January 2023, 43 (1) 509;
Back to top
PreviousNext

In this issue

Anticancer Research: 43 (1)
Anticancer Research
Vol. 43, Issue 1
January 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Use of Conditioned Extracellular Matrix as a Tissue-engineered Tumor Matrisome for Prostate Cancer and Melanoma Immunotherapy
  • Devitalization of Glioblastoma Cancer Cells by Non-invasive Physical Plasma: Modulation of Proliferative Signalling Cascades
  • Effect of Antibiotic Treatment on Attenuated Salmonella typhimurium VNP20009 Mediated Schwannoma Growth Control
  • Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal Cancer
  • Measurable Residual Disease Assessment Using Next-Generation Flow in Patients With Relapsed and Refractory Multiple Myeloma Treated With a Combination of Carfilzomib, Lenalidomide, and Dexamethasone
Sign up for alerts

Jump to

  • Experimental Studies
  • Clinical Studies
  • Special Issue on Prostate Cancer
    • Reviews
    • Experimental Studies
    • Clinical Studies
  • Corrigenda
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire